The Japanese government has come under fire after it allegedly used unspent Covid-19 relief funds to support state-funded chipmaker Rapidus. According to a report from Nikkei Asia, the move has been ...
Novavax (NASDAQ:NVAX) has received regulatory approval in Japan for its COVID-19 vaccine, Nuvaxovid, which has resulted in a milestone payment from Takeda (NYSE:TAK) (OTCPK:TKPHF), the company said on ...
Hosted on MSN
Novavax COVID-19 Vaccine Approved In Japan, Triggers Milestone Payment From Partner Takeda
Novavax, Inc. (NVAX) announced on Thursday that its COVID-19 vaccine, Nuvaxovid, has been approved in Japan, triggering a milestone payment from Japanese pharmaceutical company Takeda. The vaccine was ...
Shinzo Abe was no longer prime minister of Japan when the country first authorised COVID-19 vaccines, contrary to misleading online claims about domestic inoculation policy that were cited by posts as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results